DTIL vs. JATT, TIL, CGTX, ATHA, ELUT, GRTS, CVM, PASG, IKNA, and ATRA
Should you be buying Precision BioSciences stock or one of its competitors? The main competitors of Precision BioSciences include JATT Acquisition (JATT), Instil Bio (TIL), Cognition Therapeutics (CGTX), Athira Pharma (ATHA), Elutia (ELUT), Gritstone bio (GRTS), CEL-SCI (CVM), Passage Bio (PASG), Ikena Oncology (IKNA), and Atara Biotherapeutics (ATRA). These companies are all part of the "biological products, except diagnostic" industry.
Precision BioSciences (NASDAQ:DTIL) and JATT Acquisition (NYSE:JATT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, media sentiment, profitability, community ranking, dividends, valuation, institutional ownership and earnings.
JATT Acquisition has a net margin of 0.00% compared to Precision BioSciences' net margin of -125.84%. JATT Acquisition's return on equity of -49.58% beat Precision BioSciences' return on equity.
38.0% of Precision BioSciences shares are held by institutional investors. Comparatively, 48.0% of JATT Acquisition shares are held by institutional investors. 5.1% of Precision BioSciences shares are held by insiders. Comparatively, 20.0% of JATT Acquisition shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Precision BioSciences presently has a consensus target price of $46.33, indicating a potential upside of 323.91%. Given Precision BioSciences' higher probable upside, equities analysts plainly believe Precision BioSciences is more favorable than JATT Acquisition.
JATT Acquisition has lower revenue, but higher earnings than Precision BioSciences.
In the previous week, Precision BioSciences had 12 more articles in the media than JATT Acquisition. MarketBeat recorded 12 mentions for Precision BioSciences and 0 mentions for JATT Acquisition. Precision BioSciences' average media sentiment score of 0.61 beat JATT Acquisition's score of 0.00 indicating that Precision BioSciences is being referred to more favorably in the media.
Precision BioSciences received 87 more outperform votes than JATT Acquisition when rated by MarketBeat users.
Summary
Precision BioSciences and JATT Acquisition tied by winning 6 of the 12 factors compared between the two stocks.
Get Precision BioSciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for DTIL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding DTIL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Precision BioSciences Competitors List
Related Companies and Tools
